Effect of rosuvastatin on outcomes in chronic haemodialysis patients - design and rationale of the AURORA study
{{output}}
Background: Patients with end-stage renal disease (ESRD) are at high risk of cardiovascular events. Multiple risk factors for atherosclerosis are present in ESRD and may contribute to the increased risk of cardiovascular mortalit... ...
